BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36307664)

  • 21. Prognosis and treatment outcomes of central neurocytomas: clinical interrogation based on a single center experience.
    Byun J; Hong SH; Yoon MJ; Kwon SM; Cho YH; Kim JH; Kim CJ
    J Neurooncol; 2018 Dec; 140(3):669-677. PubMed ID: 30225773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ventricular Central Neurocytoma: Rate of Shunting and Outcome 2 Years After Total and Subtotal Excision.
    Soliman WS
    Acta Neurochir Suppl; 2017; 124():179-185. PubMed ID: 28120072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors.
    Bender L; Somme F; Lhermitte B; Ahle G; Boone M; Blonski M; Pouget C; Truc G; Cebula H; Noël G
    Chin Clin Oncol; 2021 Jun; 10(3):26. PubMed ID: 33752411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult low-grade glioma: 19-year experience at a single institution.
    Youland RS; Brown PD; Giannini C; Parney IF; Uhm JH; Laack NN
    Am J Clin Oncol; 2013 Dec; 36(6):612-9. PubMed ID: 22892428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
    Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
    J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in intracranial ependymomas in children.
    Figarella-Branger D; Civatte M; Bouvier-Labit C; Gouvernet J; Gambarelli D; Gentet JC; Lena G; Choux M; Pellissier JF
    J Neurosurg; 2000 Oct; 93(4):605-13. PubMed ID: 11014538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Adjuvant Radiotherapy in Patients with Central Neurocytoma: A Multicentric International Analysis.
    Samhouri L; Meheissen MAM; Ibrahimi AKH; Al-Mousa A; Zeineddin M; Elkerm Y; Hassanein ZMA; Ismail AA; Elmansy H; Al-Hanaqta MM; Al-Azzam OA; Elsaid AA; Kittel C; Micke O; Stummer W; Elsayad K; Eich HT
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
    Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
    Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Factors affecting on long-time survival in patients with stage Ⅲ thoracic esophageal carcinoma after esophagectomy].
    Yang Q; Wang YX; He M; Li J; Qi Z; Zhu SC; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):530-7. PubMed ID: 27531268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central Neurocytoma Treatment Modalities: A Systematic Review Assessing the Outcomes of Combined Maximal Safe Resection and Radiotherapy with Gross Total Resection.
    Mahavadi AK; Patel PM; Kuchakulla M; Shah AH; Eichberg D; Luther EM; Komotar RJ; Ivan ME
    World Neurosurg; 2020 May; 137():e176-e182. PubMed ID: 32001392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma.
    Randolph DM; McTyre ER; Paulsson AK; Holmes JA; Hinson WH; Lesser GJ; Strowd R; Lo HW; Laxton AW; Tatter SB; Debinski W; Chan MD
    Clin Neurol Neurosurg; 2016 Dec; 151():73-78. PubMed ID: 27816029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of postoperative radiotherapy for the treatment of gangliogliomas.
    Rades D; Zwick L; Leppert J; Bonsanto MM; Tronnier V; Dunst J; Schild SE
    Cancer; 2010 Jan; 116(2):432-42. PubMed ID: 19908258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.
    Wang C; Kaprealian TB; Suh JH; Kubicky CD; Ciporen JN; Chen Y; Jaboin JJ
    Neuro Oncol; 2017 Sep; 19(9):1263-1270. PubMed ID: 28371851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
    Koo T; Lim DH; Seol HJ; Dho YS; Kim IH; Chang JH; Lee J; Jung TY; Gwak HS; Cho KH; Hong CK; Lee IJ; Kim E; Kim JH; Hong YK; Jang HS; Kim CY; Kim IA; Kim SH; Kim YI; Kim EY; Kim WC; Hong S
    J Neurooncol; 2018 Nov; 140(2):445-455. PubMed ID: 30097825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients].
    Rades D; Fehlauer F; Schild S; Lamszus K; Alberti W
    Strahlenther Onkol; 2003 Apr; 179(4):213-8. PubMed ID: 12707710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
    Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
    World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study.
    Wang J; Yan L; Ai P; He Y; Guan H; Wei Z; He L; Mu X; Liu Y; Peng X
    Neurosurg Rev; 2021 Jun; 44(3):1447-1455. PubMed ID: 32529528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival outcomes of intracranial extraventricular neurocytomas: a systematic review and individual patient data meta-analysis.
    Kweh BTS; Asaid M; Khoo B; Donaldson C; Lokan J; Gan HK; Gonzalvo AC
    J Neurosurg; 2024 May; 140(5):1243-1253. PubMed ID: 38000064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.